Mesoblast Ltd
ASX:MSB

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
ASX:MSB
Watchlist
Price: 1.505 AUD 1.35% Market Closed
Market Cap: 1.7B AUD
Have any thoughts about
Mesoblast Ltd?
Write Note

Wall Street
Price Targets

MSB Price Targets Summary
Mesoblast Ltd

Wall Street analysts forecast MSB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MSB is 1.748 AUD with a low forecast of 1.111 AUD and a high forecast of 2.741 AUD.

Lowest
Price Target
1.111 AUD
26% Downside
Average
Price Target
1.748 AUD
16% Upside
Highest
Price Target
2.741 AUD
82% Upside
Mesoblast Ltd Competitors:
Price Targets
DNLI
Denali Therapeutics Inc
72% Upside
GBIO
Generation Bio Co
421% Upside
LTRN
Lantern Pharma Inc.
629% Upside
096530
Seegene Inc
68% Upside
GILD
Gilead Sciences Inc
8% Upside
ALEC
Alector Inc
256% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
54% Upside
9688
Zai Lab Ltd
89% Upside

Revenue
Forecast

Revenue Estimate
Mesoblast Ltd

For the last 8 years the compound annual growth rate for Mesoblast Ltd's revenue is -22%. The projected CAGR for the next 3 years is 246%.

-22%
Past Growth
246%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mesoblast Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

Net Income Estimate
Mesoblast Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MSB's stock price target?
Price Target
1.748 AUD

According to Wall Street analysts, the average 1-year price target for MSB is 1.748 AUD with a low forecast of 1.111 AUD and a high forecast of 2.741 AUD.

What is Mesoblast Ltd's Revenue forecast?
Projected CAGR
246%

For the last 8 years the compound annual growth rate for Mesoblast Ltd's revenue is -22%. The projected CAGR for the next 3 years is 246%.

Back to Top